A biomedical engineer by training with 15+ years in supply chain operations, Andy built SCIP after experiencing firsthand the ...
UCLA and North Texas cardiologists debate universal AFib monitoring at HRS 2026, with concerns over data overload vs. disease ...
For most medical device manufacturers, this is not an unusual scenario. It is a routine one.
Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...
Kezar Life Sciences is a biotech, not a medical device company, but the mechanics work the same way for any company with a ...
At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...
Pulse Biosciences is positioning its nanosecond PFA technology as a game-changer in the competitive atrial fibrillation ...
Verve Medical's renal pelvic denervation therapy leverages location to deliver a targeted, minimally invasive treatment for ...
After a shove from European Parliament, EU member states, and industry stakeholders, the European Commission (EC) issued ...
Boston Scientific faces securities fraud lawsuit alleging withheld info on declining EP market share, unsustainable growth, ...
MD+DI Senior Editor Amanda Pedersen weighs in on the latest politicized policies proposed by the HHS Secretary Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results